Total Payments
$692,161
2024 Payments
$25,344
Companies
10
Transactions
847
Medicare Patients
499
Medicare Billing
$32,470
Payment Breakdown by Category
Other$605,603 (87.5%)
Travel$35,960 (5.2%)
Consulting$35,610 (5.1%)
Food & Beverage$14,937 (2.2%)
Education$51.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $605,603 | 252 | 87.5% |
| Travel and Lodging | $35,960 | 328 | 5.2% |
| Consulting Fee | $35,610 | 4 | 5.1% |
| Food and Beverage | $14,937 | 262 | 2.2% |
| Education | $51.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $302,065 | 374 | $0 (2024) |
| Amarin Pharma Inc. | $154,236 | 202 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $89,439 | 124 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $71,643 | 91 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $35,946 | 14 | $0 (2019) |
| Esperion Therapeutics, Inc. | $29,124 | 24 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $9,657 | 15 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $26.15 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $13.12 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $12.29 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,344 | 34 | Amgen Inc. ($20,478) |
| 2023 | $18,685 | 25 | Amgen Inc. ($18,685) |
| 2022 | $46,405 | 30 | Amgen Inc. ($31,165) |
| 2021 | $35,579 | 29 | Esperion Therapeutics, Inc. ($17,823) |
| 2020 | $84,711 | 120 | Amarin Pharma Inc. ($43,066) |
| 2019 | $214,719 | 279 | Amarin Pharma Inc. ($87,759) |
| 2018 | $122,014 | 151 | Amgen Inc. ($71,121) |
| 2017 | $144,704 | 179 | Amgen Inc. ($57,821) |
All Payment Transactions
847 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $100.50 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $517.00 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Cardiology | ||||||
| 07/16/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,640.00 | General |
| Category: cardiovascular | ||||||
| 07/10/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Travel and Lodging | Cash or cash equivalent | $115.24 | General |
| Category: cardiovascular | ||||||
| 07/10/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $90.92 | General |
| Category: cardiovascular | ||||||
| 07/10/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: cardiovascular | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $109.88 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $104.52 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $23.50 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Cardiology | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,325.00 | General |
| Category: Cardiology | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Cardiology | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $517.00 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,100.00 | General |
| Category: Cardiology | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $517.00 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $18.25 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $12.06 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 76 | 87 | $13,601 | $4,606 |
| 2022 | 2 | 119 | 147 | $13,366 | $7,633 |
| 2021 | 2 | 136 | 174 | $20,456 | $10,271 |
| 2020 | 3 | 168 | 198 | $23,923 | $9,960 |
Total Patients
499
Total Services
606
Medicare Billing
$32,470
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 34 | 41 | $7,667 | $2,678 | 34.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 30 | 33 | $4,257 | $1,420 | 33.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $1,677 | $507.96 | 30.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 63 | 71 | $7,668 | $4,510 | 58.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 56 | 76 | $5,698 | $3,122 | 54.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 85 | 116 | $14,922 | $7,784 | 52.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 51 | 58 | $5,534 | $2,487 | 44.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 89 | 107 | $14,142 | $6,629 | 46.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 45 | 57 | $4,817 | $2,067 | 42.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 34 | 34 | $4,964 | $1,265 | 25.5% |
About Dr. David Strobl, DO
Dr. David Strobl, DO is a Cardiovascular Disease healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861490658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Strobl, DO has received a total of $692,161 in payments from pharmaceutical and medical device companies, with $25,344 received in 2024. These payments were reported across 847 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($605,603).
As a Medicare-enrolled provider, Strobl has provided services to 499 Medicare beneficiaries, totaling 606 services with total Medicare billing of $32,470. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lansing, MI
- Active Since 07/14/2005
- Last Updated 06/22/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861490658
Products in Payments
- Repatha (Biological) $302,065
- Vascepa (Drug) $154,236
- PRALUENT ALIROCUMAB INJECTION (Biological) $83,109
- PRALUENT (Drug) $71,624
- NEXLIZET (Drug) $29,073
- Livalo (Drug) $13,336
- ENTRESTO (Drug) $9,657
- PRALUENT (Biological) $6,357
- NEXLETOL (Drug) $51.00
- MULTAQ (Drug) $19.11
- Kanuma (Drug) $13.12
- SHINGRIX (Biological) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lansing
Dr. Chad Link, Do, DO
Cardiovascular Disease — Payments: $504,002
Cardiovascular Disease $504,002
Dr. Milind Karve, Md, MD
Cardiovascular Disease — Payments: $82,678
Cardiovascular Disease $82,678
Robert Gumbita, Do, DO
Cardiovascular Disease — Payments: $52,495
Cardiovascular Disease $52,495
Dr. Peter Burke, Md, MD
Cardiovascular Disease — Payments: $40,258
Cardiovascular Disease $40,258
Dr. Mohammed Qintar, M.d, M.D
Cardiovascular Disease — Payments: $34,799
Cardiovascular Disease $34,799
Dr. Nam Cho, Do, DO
Cardiovascular Disease — Payments: $22,532
Cardiovascular Disease $22,532